
Herbs & Botanicals · Herbs · Soothing inner bark, with low-certainty evidence and little human research
Slippery Elm
Ulmus rubra Muhl. (also written Ulmus fulva Michx.) · also called Slippery elm, red elm, gray elm, soft elm, Rot-Ulme (German), orme rouge (French)
Slippery elm is an elm tree of eastern North America. Its dried inner bark makes a slippery gel when mixed with water. This gel, called mucilage, is the reason it is traditionally taken as a bark drink, powder or lozenge to soothe the throat and gut.
General information, not medical advice. Last substantive update · Not medically reviewed. A named clinician has not signed off on this page. How this page is made
About Slippery Elm
Slippery elm (Ulmus rubra) is a North American tree whose inner bark makes a soothing gel. It is used for sore throat, cough and gut upset, mostly by tradition. The only human data are one small trial of a multi-herb tea for sore throat, uncontrolled studies of blends for bowel and stomach symptoms, and an observational study of Essiac. The safest reading is a gentle traditional remedy with unproven benefits and a few cautions.
What it is
Slippery elm is Ulmus rubra, a tree in the elm family. The older name Ulmus fulva is the same tree. The inner bark is dried and ground to a powder.
The bark is rich in mucilage. In water it forms a slippery gel, which is the basis of the traditional idea that it coats and soothes the throat and gut. That coating has not been measured in people.
What the research shows
One double-blind trial of 60 adults found a multi-herb tea that contains slippery elm eased sore throat pain for a short time more than a placebo tea. We found no trial of slippery elm alone.
For bowel and stomach problems, studies tested blends: a small open study in irritable bowel syndrome, a seven-ingredient gut formula, and a detox blend that did nothing. A cohort of women with breast cancer found no benefit from Essiac. Laboratory studies show antioxidant and antibacterial activity, but a dish is not a body.
Amounts
This page does not give amounts. Ask a doctor or pharmacist what suits you.
At a glance
Traditional uses history, not proof
- Sore throat and cough: bark drink or lozenge.
- Gut upset and irritation: bark powder in water.
- Skin rash, irritation and sores: a paste applied to the skin.
- One of the four herbs in Essiac tea.
Studied for research
- Sore throat: short relief in one trial of a multi-herb tea, low
- Irritable bowel syndrome with constipation: open study of a blend, very low
- Heartburn and indigestion: only blends, very low
- Inflammatory bowel disease, skin and cancer: no human proof
Main compounds
- Mucilage, a gel-forming fibre made of sugars
- Galactose-based sugars in the mucilage
- Tannins (gallic and tannic acid) found in some barks
Common forms
- Inner-bark powder mixed with water
- Lozenges
- Herbal teas and blends
- Poultice for the skin
Research links: LiverTox: Slippery Elm (US National Institutes of Health) · Throat Coat sore throat trial (abstract) · Memorial Sloan Kettering: Slippery Elm · Research Library · Genes & Biomarkers Library
The plant and its history
- Accepted scientific name
- Ulmus rubra Muhl. (slippery elm, red elm)
- Naming authority
- Muhlenberg (GBIF lists the author as Muhl.). Ulmus fulva Michx. is a synonym (GBIF key 5361868).
- Synonyms
- Ulmus fulva Michx.
- Common names
- Slippery elm (English); Red elm (English); Gray elm (English); Soft elm (English); Rot-Ulme (German); Orme rouge (French); Orme gras (French); Rode iep (Dutch)
- Botanical family
- Ulmaceae (elm family, order Rosales).
- Classification
- Plantae > Tracheophyta > Magnoliopsida > Rosales > Ulmaceae > Ulmus > Ulmus rubra
- Native range
- Eastern North America (Wikipedia: southeastern North Dakota east to Maine and southern Quebec, south to northern Florida, west to eastern Texas). NOT verified from a primary source.
- Habitat
- Not verified in a source read. Wikipedia says moist uplands, tolerates dry soils (NOT verified).
- What the plant looks like
- Roots: Not part of medicinal use.; Stems: Inner bark (the layer under the outer bark) is the medicinal part; it is mucilaginous and edible per Wikipedia (NOT verified).; Leaves: Dried ground leaves can be made into tea per Wikipedia (NOT verified); not the studied part.; Flowers: Not described in sources read.; Fruit: Not described in sources read.
- Cultivation
- United Plant Savers: cultivation efforts have been sporadic and inadequate, cultivated bark is a small share of the trade (under 10,000 lb in AHPA surveys), and there are no published scientific growing trials.
- Harvest and processing
- UPS: bark is usually taken from trees or branches over one inch across, peels most easily late March to early June, is usually "rossed" (outer bark scraped off), and should be dried within a week. Thin vertical strips are recommended because girdling kills the tree.
- Look-alikes and adulterants
- Name: American elm (Ulmus americana); Note: Another native elm. UPS says slippery elm succumbs to many of the same diseases as American elm. Whether American elm bark is substituted in products was not found.; Name: Siberian elm (Ulmus pumila); Note: A non-native, invasive elm; one 2010 paper in the search results studies its hybridisation. Whether it appears in slippery elm products was not found.; Name: Old name Ulmus fulva; Note: Same species. Labels using it are not a different plant.
- Sustainability and conservation
- IUCN Least Concern (Wikipedia, citing Stritch 2018; NOT verified). United Plant Savers At-Risk List because of reliance on wild harvest. Wikipedia says it is reputedly less susceptible to Dutch elm disease than other American elms; UPS says Dutch elm disease and elm yellows are killing it.
The plant and the parts used

Traditional use and history history, not clinical proof
| Tradition or era | Documented use | Source |
|---|---|---|
| North America, traditional use | Inner bark used as a drink or paste for sore throat, cough, gut upset and skin sores (Memorial Sloan Kettering; LiverTox). Essiac, a four-herb tea that includes it, is described as reportedly developed by the Ojibwa people of Canada. | s-mskcc-slippery-elm |
| 19th century surgery (1837 title) | PubMed lists a paper on slippery elm bark used for surgical bougies, tents and catheters (1837), apparently because the bark swells when wet. Only the title was seen. | p38080966 |
| Mid-20th century laboratory chemistry | 1946 and 1950 chemistry papers analysed the bark mucilage and found a methylated galactose sugar among its breakdown products (titles only). | p15400433 |
| Modern market | Sold as powder, capsules, lozenges and in teas; the herbal tea Throat Coat lists slippery elm bark second in its current ingredients. Wild-harvested bark was 78,000 to 353,000 lb a year (AHPA surveys 1999-2010). | s-ups-slippery-elm-burkhart |
| Modern regulation | WebMD says the FDA has not reviewed it. Sold over the counter in the US as a demulcent per Wikipedia (NOT verified). No EU herbal monograph found. | s-webmd-slippery-elm |
Traditional use shows how a plant was used. It does not show that a supplement works or is safe today.
What is inside, and how it may work
What the plant contains and how those compounds act in cells and animals. Laboratory and animal mechanisms are not proven effects in people.
Main compounds
| Compound | Family | Where it is concentrated | Activity studied | Level of evidence |
|---|---|---|---|---|
| Mucilage (galactose- and other-sugar polysaccharide) | polysaccharide / soluble fibre | Inner bark | Forms a gel with water; the traditional basis of the demulcent (soothing, coating) use. Not measured in people. 7 8 | Laboratory research |
| D-Galactose (sugar unit of the mucilage) PubChem 6036 | monosaccharide | Inner bark mucilage | A 1950 paper title reports a methylated form (3-methyl D-galactose) from the mucilage breakdown; amounts not read. 8 | Laboratory research |
| Tannins (for example gallic acid CID 370, tannic acid CID 16129778) | polyphenols | Bark | The KCNQ5 paper says gallic acid and tannic acid are common to the active barks tested; it does not say how much slippery elm contains. 13 | Laboratory research |
Mechanisms, receptors and pathways
| Target or pathway | Gene or receptor | What was found | Level |
|---|---|---|---|
| Demulcent (coating) action of mucilage | None identified | Not measured. The explanation is that the gel coats irritated throat and gut lining. 25 | Pharmacological theory |
| Radical scavenging | Superoxide, peroxyl radicals, peroxynitrite | Extracts scavenged radicals in test tubes and reduced oxygen radicals from colitis biopsies in a dish. 10 6 | Laboratory research |
| Antibacterial action against Streptococcus pyogenes | Bacterial cell wall and membrane | Ethanol extract of inner bark: MIC 62.5 microgram/mL, MBC 125 microgram/mL in the laboratory (the abstract notes cell wall degradation for the four most effective extracts). 21 | Laboratory research |
| Gut bacteria fermentation | Butyrate-producing bacteria | Ulmus rubra raised butyrate-producing bacteria in stool cultures. 15 | Laboratory research |
| Potassium channel activation | KCNQ5 (voltage-gated potassium channel) | 1% slippery elm bark extract strongly activated KCNQ5 in frog eggs; arteries not shown for slippery elm. 13 | Laboratory research |
Absorption, metabolism and elimination
- Absorption
- No human data on absorption of any slippery elm compound.
- Distribution
- No data.
- Metabolism
- No human data. Stool culture work shows gut bacteria change in the presence of Ulmus rubra.
- Elimination
- No data.
- Bioavailability
- Not established.
Isolated compounds versus whole extracts
No single compound has been shown to explain the traditional effects. The leading idea is the whole mucilage gel, which only works as a gel, so isolated sugars would not do the same.
Nutritional composition
Slippery elm bark powder is a fibre-rich plant food but no nutrient table was read, so none is given here.
2 low certainty8 very low certainty4 not enough evidence1 evidence against
What was looked at
The 15 benefits and uses checked for Slippery Elm, each with how strong the evidence is. Tap one to open it.
- Sore throat (pharyngitis): short-term pain reliefLow certainty
- Cough, bronchitis and coldsNot enough evidence
- Activity against strep throat bacteria (laboratory only)Very low certainty
- Heartburn and acid reflux (GERD)Not enough evidence
- Indigestion and upper-gut symptoms (seven-ingredient formula)Very low certainty
- Antioxidant activity of slippery elm bark (laboratory only)Very low certainty
- Irritable bowel syndrome with constipation (mixed-herb formula)Very low certainty
- Constipation or diarrhoea on its ownNot enough evidence
- Crohn disease and ulcerative colitisVery low certainty
- Gut lining leakiness and gut bacteriaVery low certainty
- Detox, body composition and waist sizeLow certainty
- Skin irritation, rash and sores (poultice)Not enough evidence
- Psoriasis (inside a whole-diet programme)Very low certainty
- Cancer: Essiac herbal tea (a formula that contains slippery elm)Evidence against
- Blood vessel relaxation (cell and animal tissue only)Very low certainty
Lab markers tracked in the studies
Throat pain on swallowingBacterial growth stopped in a dish (MIC and MBC)Digestive symptom questionnaire scoresUse of proton pump inhibitor medicinesFree radical scavenging in the laboratoryBowel movement frequencyStool consistencyAbdominal pain, bloating and strainingIntestinal permeability (lactulose-to-mannitol ratio)Gut bacteria mixBody composition and waist circumferencePsoriasis severity scores (PASI, PSS)Health-related quality of life in breast cancer (FACT-B)
What is Slippery Elm good for?
The main proposed uses and how strong the human evidence is for each. Nothing is above low certainty, and most results come from blends of several herbs.
Benefits, one by one
Each card is a research question, not a promise. Tap a goal to filter. Open a card to see the studies, doses and limits.
Sore throat (pharyngitis): short-term pain relief
Low certaintyOne trial of a multi-herb tea that contains slippery elm eased throat pain for a short time. It cannot tell us what slippery elm does on its own.
3 studiesTea in the trial. Slippery elm is also sold as lozenges and powder; n…
Studies, doses and limits
What the trials found
One double-blind placebo-controlled trial of 60 adults with acute pharyngitis tested Throat Coat, a multi-herb demulcent tea (the current label lists slippery elm bark second after licorice root, alongside marshmallow root, wild cherry bark, fennel, cinnamon and orange peel; the 2003 recipe was not checked). Pain on swallowing was lower than with placebo tea for about 30 minutes after the first dose. We found no trial of slippery elm alone for sore throat. Memorial Sloan Kettering says slippery elm may ease a minor sore throat but human data are lacking.
Results
Throat pain on swallowing fell more with the tea than with placebo tea over the first 30 minutes after one dose. Relief was temporary.
Effect sizes as reported
SPID -43.8 versus -16.5 (p = 0.012); TOTPAR 53.6 versus 32.4 (p = 0.031). Mean differences with confidence intervals not given in the abstract.
Why this rating
One small trial (60 people) of a combination product, with short follow-up. The effect cannot be credited to slippery elm. The product maker may have funded or supplied the trial (not stated).
Form and dose studied
Tea in the trial. Slippery elm is also sold as lozenges and powder; none of those was tested alone.
Who was studied
Adults with a sore throat, 2 to 7 days of symptoms.
Limits
Multi-herb product. Licorice root is a main ingredient and has its own safety limits. Only a few minutes to an hour of relief was measured. A sore throat with fever, trouble swallowing or breathing needs a doctor.
Why researchers looked
Slippery elm bark and lozenges are an old American remedy for a sore, scratchy throat. The gel-like mucilage is thought to coat the throat.
Traditional use
Used by Native American peoples and later by settlers as a bark tea and lozenge for sore throat and cough (traditional use; Memorial Sloan Kettering describes use for sore throat and cough).
Proposed mechanism Pharmacological theory
Slippery elm inner bark is rich in mucilage, a gel-forming plant fibre that coats the lining of the throat and gut when mixed with water. This coating idea (called a demulcent action) is the traditional explanation. It is a theory from how the material behaves; no study we read measured it in people.
A proposed mechanism does not show that the effect happens in people.
Allergy is possible. See the safety file for mixing with other medicines.
Cough, bronchitis and colds
Not enough evidenceSlippery elm is traditionally used for cough and chest colds. No human trial of slippery elm alone for cough or colds was found.
2 studiesNot tested alone.
Studies, doses and limits
What the trials found
No clinical trial of slippery elm for cough, bronchitis or colds was found in PubMed. A 2024 review of traditional Iranian remedies lists slippery elm as an expectorant and an immune-stimulating plant but reports no trial for it. Memorial Sloan Kettering says there is no evidence it treats infections.
Results
No human results for cough or colds.
Effect sizes as reported
No numbers.
Why this rating
No human trials; the only support is traditional use and a literature list.
Form and dose studied
Not tested alone.
Limits
A review that lists traditional uses is not evidence that the plant works. Lab studies of alcohol extracts killing bacteria do not show a benefit from a swallowed tea.
Why researchers looked
The bark has long been taken as a soothing drink for dry coughs, and some traditional-medicine reviews list it among expectorant and immune-boosting plants.
Traditional use
Traditional use for cough and bronchitis (Memorial Sloan Kettering lists cough and bronchitis).
Proposed mechanism Pharmacological theory
Slippery elm inner bark is rich in mucilage, a gel-forming plant fibre that coats the lining of the throat and gut when mixed with water. This coating idea (called a demulcent action) is the traditional explanation. It is a theory from how the material behaves; no study we read measured it in people.
A proposed mechanism does not show that the effect happens in people.
A cough lasting more than a few weeks, blood in phlegm, or breathlessness needs a doctor.
Activity against strep throat bacteria (laboratory only)
Very low certaintyIn a laboratory dish an alcohol extract of slippery elm inner bark stopped the growth of the bacterium behind strep throat. This has not been tested in people.
1 studiesEthanol extract of inner bark in the laboratory.
Studies, doses and limits
What the trials found
One laboratory study of 14 plant extracts. The authors picked sage leaf and purple coneflower flower as the most promising, not slippery elm.
Results
Minimum inhibitory concentration 62.5 microgram/mL and minimum bactericidal concentration 125 microgram/mL for the most effective extracts, including slippery elm inner bark.
Effect sizes as reported
MIC 62.5 microgram/mL; MBC 125 microgram/mL
Why this rating
Laboratory dish only; no animal or human data.
Form and dose studied
Ethanol extract of inner bark in the laboratory.
Who was studied
Bacteria in a dish.
Limits
A tea or lozenge in the mouth is not an alcohol extract at a measured concentration. Strep throat is a bacterial infection that can need antibiotics.
Why researchers looked
Researchers screened plant extracts for activity against Streptococcus pyogenes to find natural options for strep throat.
Traditional use
Not a traditional claim; a laboratory screen.
Proposed mechanism Laboratory research
Alcohol extracts of slippery elm inner bark damaged bacterial cell walls and membranes in the laboratory. The abstract names the four most effective extracts as licorice root, purple coneflower, sage leaf and slippery elm inner bark.
A proposed mechanism does not show that the effect happens in people.
Do not use slippery elm instead of a test and treatment for suspected strep throat (fever, swollen glands, no cough).
Heartburn and acid reflux (GERD)
Not enough evidenceSlippery elm is a popular home remedy for heartburn, but no trial of it alone has been found. A review calls the evidence for it thin.
1 studiesNot tested alone.
Studies, doses and limits
What the trials found
A 2019 critical review of popular remedies for reflux and chest pain lists slippery elm among herbal products under study and says a large gap remains between anecdote and evidence. We found no trial of slippery elm alone for reflux. In a seven-ingredient formula that included slippery elm, heartburn improved in an uncontrolled study (see the next item).
Results
Nothing measured for slippery elm alone.
Effect sizes as reported
No numbers for slippery elm alone.
Why this rating
Only a review abstract naming slippery elm among other remedies; no controlled trial.
Form and dose studied
Not tested alone.
Limits
Only the review abstract was read. Heartburn that is frequent, or comes with trouble swallowing, weight loss, black stools or chest pain, needs a doctor.
Why researchers looked
The coating idea suggests slippery elm could soothe an irritated food pipe (oesophagus).
Traditional use
Folk use for stomach upset and gut irritation (LiverTox: sore throat and gastrointestinal upset).
Proposed mechanism Pharmacological theory
Slippery elm inner bark is rich in mucilage, a gel-forming plant fibre that coats the lining of the throat and gut when mixed with water. This coating idea (called a demulcent action) is the traditional explanation. It is a theory from how the material behaves; no study we read measured it in people.
A proposed mechanism does not show that the effect happens in people.
Chest pain should never be put down to reflux without a check. Mucilage may slow the absorption of other medicines.
Indigestion and upper-gut symptoms (seven-ingredient formula)
Very low certaintyIn an uncontrolled study, a powder with slippery elm and six other ingredients was followed by fewer stomach and bowel symptoms. Without a placebo group this does not show the formula works, and it says little about slippery elm.
1 studiesA powder taken at 5 g/day then 10 g/day (slippery elm amount not give…
Studies, doses and limits
What the trials found
43 adults completed a 16-week study with a control phase and then 5 g and 10 g a day for 4 weeks each. The authors report 60 to 80% improvement in symptom frequency and severity (indigestion, heartburn, nausea, constipation or diarrhoea, abdominal pain, wind) and that almost half of the people with upper-gut symptoms taking proton pump inhibitors no longer needed them by the end. There was no placebo group or blinding.
Results
Symptom questionnaires improved after the formula compared with the control phase.
Effect sizes as reported
Improvement of 60 to 80% (authors, abstract); almost half stopped proton pump inhibitors.
Why this rating
Uncontrolled, small, multi-ingredient, self-reported outcomes; slippery elm cannot be credited.
Form and dose studied
A powder taken at 5 g/day then 10 g/day (slippery elm amount not given in the abstract).
Who was studied
Adults with digestive disorders in Australia.
Limits
Never copy the stopping of acid-reducing medicines from this study; change medicines only with your doctor.
Why researchers looked
Researchers tested a ready-made gut-relief powder for people with digestive disorders.
Traditional use
Not a traditional product; a modern blend.
Proposed mechanism Pharmacological theory
Not studied for slippery elm separately. The formula also holds curcumin, aloe vera, guar gum, pectin, peppermint oil and glutamine, each with its own possible effects.
A proposed mechanism does not show that the effect happens in people.
Mucilage and fibres may change absorption of other medicines.
Antioxidant activity of slippery elm bark (laboratory only)
Very low certaintySlippery elm bark extracts mopped up reactive oxygen molecules in test tubes. This is a lab finding, not a health benefit shown in people.
2 studiesExtracts in a dish.
Studies, doses and limits
What the trials found
Test-tube and biopsy-tissue work only (see also the bowel file for the colitis biopsy study).
Results
Dose-dependent scavenging reported; no numbers in the abstracts.
Why this rating
Laboratory only.
Form and dose studied
Extracts in a dish.
Who was studied
Test tubes and tissue samples.
Limits
Antioxidant activity in a dish does not show a benefit in the body.
Why researchers looked
Free radicals made by inflamed tissue may add to damage, so researchers screen herbs for scavenging.
Traditional use
Not traditional.
Proposed mechanism Laboratory research
Slippery elm extract scavenged superoxide and peroxyl radicals in cell-free tests, reduced oxygen radical release from colitis biopsies in a dish, and ranked fifth for peroxynitrite scavenging among 28 herbs.
A proposed mechanism does not show that the effect happens in people.
None specific.
Irritable bowel syndrome with constipation (mixed-herb formula)
Very low certaintyIn a small open study, a powder with slippery elm, lactulose, oat bran and licorice root was followed by easier, more frequent bowel movements and less pain. The other ingredients could explain this on their own.
2 studiesPowdered mixtures; exact amounts not in the abstract.
Studies, doses and limits
What the trials found
One open-label, uncontrolled pilot study of 31 adults with IBS (Rome II). The constipation-predominant blend (slippery elm bark, lactulose, oat bran, licorice root; n=10) was followed by a 20% rise in bowel movement frequency, less straining, abdominal pain and bloating, and softer stools. A second blend with slippery elm for diarrhoea-predominant or mixed IBS (n=21) lifted some symptoms but did not improve bowel habit by the authors' own conclusion. There was no placebo group.
Results
Constipation-predominant group: more frequent, softer stools and fewer symptoms. Diarrhoea/mixed group: some symptoms eased, bowel habit not improved.
Effect sizes as reported
+20% bowel movement frequency (p = 0.016); straining p < 0.0001; abdominal pain p = 0.032; bloating p = 0.034 (C-IBS group)
Why this rating
Ten people in the constipation group, no control group, no blinding, and lactulose and oat bran are known to ease constipation. Slippery elm cannot be credited.
Form and dose studied
Powdered mixtures; exact amounts not in the abstract.
Who was studied
Adults with IBS in Australia.
Limits
Not a placebo-controlled trial. Licorice root in the blend has its own safety limits (blood pressure, potassium).
Why researchers looked
Slippery elm bark powder is often used by people with irritable bowel syndrome (IBS). Researchers tested two blends.
Traditional use
Traditional use for gut irritation and bowel regularity (Memorial Sloan Kettering lists constipation-predominant IBS in a formula).
Proposed mechanism Pharmacological theory
Slippery elm inner bark is rich in mucilage, a gel-forming plant fibre. Mixed with water it forms a slippery gel that is thought to coat and soothe the gut lining and to add soft bulk to stool. This is a theory from how the material behaves; no study we read measured these effects in people.
A proposed mechanism does not show that the effect happens in people.
Mucilage may change how other medicines are absorbed.
Constipation or diarrhoea on its own
Not enough evidenceSlippery elm is traditionally used for both, but no trial tested it alone for either.
3 studiesNot tested alone.
Studies, doses and limits
What the trials found
No clinical trial of slippery elm alone for constipation or diarrhoea was found. The only data are inside multi-ingredient studies (IBS formulas and the seven-ingredient gut formula).
Results
Nothing measured for slippery elm alone.
Effect sizes as reported
No numbers.
Why this rating
No trials of slippery elm alone.
Form and dose studied
Not tested alone.
Limits
Persistent change in bowel habit, blood in stool, or weight loss needs a doctor.
Why researchers looked
Gel-forming fibre can soften and bulk stool, or firm loose stool, which is why mucilage herbs are used both ways.
Traditional use
Traditional use for bowel irregularity. Memorial Sloan Kettering says evidence is lacking for diarrhoea.
Proposed mechanism Pharmacological theory
Slippery elm inner bark is rich in mucilage, a gel-forming plant fibre. Mixed with water it forms a slippery gel that is thought to coat and soothe the gut lining and to add soft bulk to stool. This is a theory from how the material behaves; no study we read measured these effects in people.
A proposed mechanism does not show that the effect happens in people.
Mucilage should be taken with enough water.
Crohn disease and ulcerative colitis
Very low certaintyNo trial in people with inflammatory bowel disease was found. Only laboratory tests show slippery elm extract calms oxygen radicals in colitis tissue.
2 studiesExtract applied to biopsies.
Studies, doses and limits
What the trials found
No human trial found. A laboratory study used cell-free tests and colon biopsies from people with active ulcerative colitis; a 2017 review of herb-drug interactions in older people with IBD lists Ulmus rubra among the herbs discussed, but the abstract does not give its findings.
Results
In-dish antioxidant effect only.
Effect sizes as reported
Dose-dependent scavenging; no numbers in abstract
Why this rating
Laboratory evidence only; the review abstract gave no slippery elm result.
Form and dose studied
Extract applied to biopsies.
Who was studied
Biopsies from active ulcerative colitis.
Limits
Antioxidant effects in tissue samples do not show that slippery elm controls IBD. Not a substitute for IBD medicines.
Why researchers looked
Many people with inflammatory bowel disease (IBD) try herbs, and slippery elm is one they report using.
Traditional use
Used by people with IBD as a bark powder or drink; no formal tradition for IBD.
Proposed mechanism Laboratory research
Extract reduced oxygen radical release from inflamed colon biopsies in a dish, similar to the medicine 5-ASA. The researchers say it merits formal trials.
A proposed mechanism does not show that the effect happens in people.
Mucilage may reduce the absorption of IBD medicines taken by mouth at the same time; talk to your gastroenterologist.
Gut lining leakiness and gut bacteria
Very low certaintyIn a dish, slippery elm changed the mix of bacteria in human stool samples. In a seven-ingredient formula study, tests of gut-lining leakiness and gut bacteria improved, but slippery elm cannot be credited.
2 studiesBark in culture; seven-ingredient formula at 5 and 10 g/day.
Studies, doses and limits
What the trials found
Laboratory fermentation of human stool with Ulmus rubra raised bacteria considered helpful and lowered some potential pathogens. In the uncontrolled formula study, most participants had a normal lactulose-to-mannitol permeability ratio at the end and Lactobacillus, Clostridium and Faecalibacterium prausnitzii rose; that product also contained guar gum, pectin and glutamine.
Results
Lab: butyrate producers up. Formula study: permeability ratio and bacteria improved.
Effect sizes as reported
No numbers in the abstracts.
Why this rating
One in-dish study plus an uncontrolled multi-ingredient study.
Form and dose studied
Bark in culture; seven-ingredient formula at 5 and 10 g/day.
Who was studied
Stool samples; 43 adults with digestive disorders.
Limits
Lab results do not show a health benefit. Permeability tests are not a settled measure of health.
Why researchers looked
Interest in a "leaky gut" and prebiotic effects of fibre-rich herbs.
Traditional use
Not traditional.
Proposed mechanism Laboratory research
Stool cultures grown in the laboratory with Ulmus rubra showed more butyrate-producing bacteria (butyrate is a fuel for the bowel lining).
A proposed mechanism does not show that the effect happens in people.
None specific.
Detox, body composition and waist size
Low certaintyA "detox" blend containing slippery elm did nothing for body composition, waist size or bowel symptoms compared with placebo in healthy women.
1 studiesProprietary blend, 1,350 mg per serving, daily for 4 weeks.
Studies, doses and limits
What the trials found
One double-blind randomized trial of 22 healthy young women taking a proprietary blend of papaya leaf, cascara sagrada, slippery elm, peppermint, red raspberry leaf, fenugreek, ginger and senna leaf for four weeks found no benefit or harm on body composition, waist, bowel symptoms or blood safety markers.
Results
No difference from placebo.
Effect sizes as reported
No difference from placebo
Why this rating
A well-designed but tiny trial of a blend; null result.
Form and dose studied
Proprietary blend, 1,350 mg per serving, daily for 4 weeks.
Who was studied
Healthy young women.
Limits
Tiny trial in healthy women; says nothing about people with gut problems. The blend contains two stimulant laxatives (cascara, senna).
Why researchers looked
Slippery elm appears in many "cleanse" blends.
Traditional use
Not traditional.
Proposed mechanism Pharmacological theory
No mechanism was proposed in the abstract.
A proposed mechanism does not show that the effect happens in people.
Blends with cascara or senna can cause cramps, diarrhoea and low potassium.
Skin irritation, rash and sores (poultice)
Not enough evidenceSlippery elm is traditionally applied to skin as a soothing paste, but no human study was found.
2 studiesNot tested.
Studies, doses and limits
What the trials found
No clinical trial of slippery elm on the skin was found. Memorial Sloan Kettering says the mucilage is thought to be soothing but human data are lacking. In a five-person psoriasis case series, slippery elm bark water was drunk as part of a whole-diet programme, so it cannot be credited.
Results
No human results for slippery elm on skin.
Effect sizes as reported
No numbers.
Why this rating
No trials.
Form and dose studied
Not tested.
Limits
Do not put it on broken or infected skin or open wounds without medical advice; the skin can react.
Why researchers looked
Mucilage is soft and gel-like, so the powder is mixed with water and used as a poultice.
Traditional use
LiverTox and Memorial Sloan Kettering list topical use for rash, irritation and skin ulcers.
Proposed mechanism Pharmacological theory
Slippery elm inner bark is rich in mucilage, a gel-forming plant fibre. Mixed with water it forms a slippery gel that is thought to coat and soothe the gut lining and to add soft bulk to stool. This is a theory from how the material behaves; no study we read measured these effects in people.
A proposed mechanism does not show that the effect happens in people.
Allergic skin reaction is possible.
Psoriasis (inside a whole-diet programme)
Very low certaintyFive people with psoriasis improved on a diet programme that included slippery elm bark water. Slippery elm cannot be credited.
1 studiesSlippery elm bark water daily as part of the programme.
Studies, doses and limits
What the trials found
In five adults the average psoriasis score (PASI) went from 18.2 to 8.7 and the permeability ratio from 0.066 to 0.026 over six months. There was no control group and the plan changed diet, fibre, oils and teas at the same time.
Results
Scores improved overall.
Effect sizes as reported
PASI 18.2 to 8.7; PSS 14.6 to 5.4 (averages of five people)
Why this rating
Five people, no control, many changes at once.
Form and dose studied
Slippery elm bark water daily as part of the programme.
Who was studied
Five adults with chronic plaque psoriasis.
Limits
Do not read this as slippery elm treating psoriasis.
Why researchers looked
A 10-day programme followed by six months of diet based on Edgar Cayce readings.
Traditional use
Not a standard traditional use.
Proposed mechanism Pharmacological theory
None proposed for slippery elm.
A proposed mechanism does not show that the effect happens in people.
None specific.
Cancer: Essiac herbal tea (a formula that contains slippery elm)
Evidence againstNo evidence that slippery elm or Essiac treats cancer. A study of women with breast cancer found no benefit to quality of life from Essiac.
3 studiesEssiac (four-herb tea), about 44 mL a day on label directions.
Studies, doses and limits
What the trials found
A retrospective cohort of 510 Ontario women with breast cancer found Essiac users did not have better quality of life or mood and did slightly worse on two subscales, probably because they had more advanced disease; only 2 women reported minor adverse events. Memorial Sloan Kettering says there is no evidence slippery elm treats cancer.
Results
No benefit on quality of life.
Effect sizes as reported
No benefit
Why this rating
The best human study found no benefit; laboratory antioxidant work is not a treatment effect.
Form and dose studied
Essiac (four-herb tea), about 44 mL a day on label directions.
Who was studied
Women with breast cancer, Ontario.
Limits
Observational, four-herb blend, cannot say whether Essiac harms or helps outcomes.
Why researchers looked
Slippery elm bark is one of the four herbs in Essiac, a tea widely promoted as a cancer remedy.
Traditional use
Essiac is described as a formula reportedly developed by the Ojibwa and popularised in Canada (the abstract says "reportedly").
Proposed mechanism Laboratory research
Essiac tea scavenged free radicals and protected DNA in test tubes, which the authors say may help explain reports of anti-cancer effects.
A proposed mechanism does not show that the effect happens in people.
Essiac contains Indian rhubarb, a laxative plant. Tell your cancer team about any herbs.
Blood vessel relaxation (cell and animal tissue only)
Very low certaintyA cell-based test found slippery elm bark extract opens a potassium channel linked to smooth muscle relaxation. The artery test was not reported for slippery elm.
1 studies1% bark extract in the laboratory.
Studies, doses and limits
What the trials found
No human data. In frog egg cells carrying the human channel, 1% slippery elm bark extract strongly activated it. Rat artery relaxation was shown for red willow, white willow and white oak, not reported for slippery elm.
Results
Channel activation in a laboratory cell model only.
Why this rating
Cells only.
Form and dose studied
1% bark extract in the laboratory.
Who was studied
Xenopus oocytes.
Limits
No evidence for any effect on blood pressure or cramps in people.
Why researchers looked
Researchers explored how bark remedies used for cramps might relax smooth muscle.
Traditional use
Bark remedies are used in Native American folk medicine for cramps.
Proposed mechanism Laboratory research
Bark tannins (gallic acid and tannic acid are named as common to the active barks) activated KCNQ5 channels; not shown for slippery elm specifically.
A proposed mechanism does not show that the effect happens in people.
None specific.
Connections to the rest of health
How Slippery Elm connects to the rest of our health knowledge graph. Every link says what kind of connection it is. A safety link (for example to the liver) is a warning, not a benefit. A study that merely mentions a topic never creates a benefit link.
Explore every connection: goals, body systems, organs, symptoms, genes
A. Wellness goals
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Calm Relaxation | Potential benefit | Low certainty | Sore throat (pharyngitis): short-term pain relief: One trial of a multi-herb tea that contains slippery elm eased throat pain for a short time. It cannot tell us what slippery elm does on its own. | 4 28 25 |
| Immune Support | Traditional use | Not enough evidence | Cough, bronchitis and colds: Slippery elm is traditionally used for cough and chest colds. No human trial of slippery elm alone for cough or colds was found. | 18 25 |
| Immune Support | Preliminary mechanism | Very low certainty | Activity against strep throat bacteria (laboratory only): In a laboratory dish an alcohol extract of slippery elm inner bark stopped the growth of the bacterium behind strep throat. This has not been tested in people. | 21 |
| Digestive Support | Traditional use | Not enough evidence | Heartburn and acid reflux (GERD): Slippery elm is a popular home remedy for heartburn, but no trial of it alone has been found. A review calls the evidence for it thin. Constipation or diarrhoea on its own: Slippery elm is traditionally used for both, but no trial tested it alone for either. | 1 9 17 25 |
| Digestive Support | Potential benefit | Very low certainty | Indigestion and upper-gut symptoms (seven-ingredient formula): In an uncontrolled study, a powder with slippery elm and six other ingredients was followed by fewer stomach and bowel symptoms. Without a placebo group this does not show the formula works, and it says little about slippery elm. Irritable bowel syndrome with constipation (mixed-herb formula): In a small open study, a powder with slippery elm, lactulose, oat bran and licorice root was followed by easier, more frequent bowel movements and less pain. The other ingredients could explain this on their own. | 17 9 25 |
| Gut Health | Potential benefit | Very low certainty | Indigestion and upper-gut symptoms (seven-ingredient formula): In an uncontrolled study, a powder with slippery elm and six other ingredients was followed by fewer stomach and bowel symptoms. Without a placebo group this does not show the formula works, and it says little about slippery elm. Irritable bowel syndrome with constipation (mixed-herb formula): In a small open study, a powder with slippery elm, lactulose, oat bran and licorice root was followed by easier, more frequent bowel movements and less pain. The other ingredients could explain this on their own. | 17 9 25 |
| Inflammation Balance | Preliminary mechanism | Very low certainty | Antioxidant activity of slippery elm bark (laboratory only): Slippery elm bark extracts mopped up reactive oxygen molecules in test tubes. This is a lab finding, not a health benefit shown in people. Crohn disease and ulcerative colitis: No trial in people with inflammatory bowel disease was found. Only laboratory tests show slippery elm extract calms oxygen radicals in colitis tissue. | 6 10 16 |
| Gut Health | Preliminary mechanism | Very low certainty | Crohn disease and ulcerative colitis: No trial in people with inflammatory bowel disease was found. Only laboratory tests show slippery elm extract calms oxygen radicals in colitis tissue. Gut lining leakiness and gut bacteria: In a dish, slippery elm changed the mix of bacteria in human stool samples. In a seven-ingredient formula study, tests of gut-lining leakiness and gut bacteria improved, but slippery elm cannot be credited. | 10 16 15 17 |
| Weight Management | Demonstrated clinical effect | Low certainty | Detox, body composition and waist size: A "detox" blend containing slippery elm did nothing for body composition, waist size or bowel symptoms compared with placebo in healthy women. | 19 |
| Healthy Skin | Traditional use | Not enough evidence | Skin irritation, rash and sores (poultice): Slippery elm is traditionally applied to skin as a soothing paste, but no human study was found. | 25 12 |
| Healthy Skin | Potential benefit | Very low certainty | Psoriasis (inside a whole-diet programme): Five people with psoriasis improved on a diet programme that included slippery elm bark water. Slippery elm cannot be credited. | 5 |
| Immune Support | Potential benefit | Evidence against | Cancer: Essiac herbal tea (a formula that contains slippery elm): No evidence that slippery elm or Essiac treats cancer. A study of women with breast cancer found no benefit to quality of life from Essiac. | 22 11 25 |
| Blood Pressure Support | Preliminary mechanism | Very low certainty | Blood vessel relaxation (cell and animal tissue only): A cell-based test found slippery elm bark extract opens a potassium channel linked to smooth muscle relaxation. The artery test was not reported for slippery elm. | 13 |
B. Body systems
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Digestive system | Drug or supplement interaction | Not enough evidence | May change how swallowed medicines are absorbed; unmeasured. Mucilage may change absorption of other medicines (unmeasured). Preparation or compound: Mucilage |
30 |
| Immune system | Adverse effect or risk | Low certainty | Allergic reaction; one case report of eosinophilic colitis. Preparation or compound: Ulmus rubra-rich product |
3 30 |
| Reproductive system | Contraindication | Not enough evidence | Avoid in pregnancy; abortifacient claim from folk use, source not shown. Preparation or compound: Whole bark |
27 30 |
| Respiratory System | Biological association | Low certainty | Studied for: Sore throat (pharyngitis): short-term pain relief Studied for: Cough, bronchitis and colds | 4 28 25 18 21 |
| Digestive System | Biological association | Not enough evidence | Studied for: Heartburn and acid reflux (GERD) Studied for: Indigestion and upper-gut symptoms (seven-ingredient formula) | 1 17 6 10 9 25 16 15 |
| Immune System | Biological association | Very low certainty | Studied for: Crohn disease and ulcerative colitis Studied for: Cancer: Essiac herbal tea (a formula that contains slippery elm) | 10 16 22 11 25 |
| Metabolism Weight | Biological association | Low certainty | Studied for: Detox, body composition and waist size | 19 |
| Integumentary System | Biological association | Not enough evidence | Studied for: Skin irritation, rash and sores (poultice) Studied for: Psoriasis (inside a whole-diet programme) | 25 12 5 |
| Cardiovascular System | Biological association | Very low certainty | Studied for: Blood vessel relaxation (cell and animal tissue only) | 13 |
C. Body parts and organs
D. Symptoms
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Sore throat | Potential benefit | Low certainty | Short relief in one trial of a multi-herb tea. Preparation or compound: Throat Coat tea (contains slippery elm) |
4 |
I. Biomarkers
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Throat pain on swallowing | Biological association | Low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 4 |
| Bacterial growth stopped in a dish (MIC and MBC) | Biological association | Very low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 21 |
| Digestive symptom questionnaire scores | Biological association | Very low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 17 |
| Use of proton pump inhibitor medicines | Biological association | Very low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 17 |
| Free radical scavenging in the laboratory | Biological association | Very low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 10 6 |
| Bowel movement frequency | Biological association | Very low certainty | Measured in trials: raised. A lab change is not the same as a health benefit. | 9 |
| Stool consistency | Biological association | Very low certainty | Measured in trials: mixed. A lab change is not the same as a health benefit. | 9 |
| Abdominal pain, bloating and straining | Biological association | Very low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 9 |
| Intestinal permeability (lactulose-to-mannitol ratio) | Biological association | Very low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 17 5 |
| Gut bacteria mix | Biological association | Very low certainty | Measured in trials: raised. A lab change is not the same as a health benefit. | 15 17 |
| Body composition and waist circumference | Biological association | Low certainty | Measured in trials: no-change. A lab change is not the same as a health benefit. | 19 |
| Psoriasis severity scores (PASI, PSS) | Biological association | Very low certainty | Measured in trials: lowered. A lab change is not the same as a health benefit. | 5 |
| Health-related quality of life in breast cancer (FACT-B) | Biological association | Low certainty | Measured in trials: no-change. A lab change is not the same as a health benefit. | 22 |
J. Genes, receptors and enzymes
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| KCNQ5 | Preliminary mechanism | In vitro | Activated by bark extracts in laboratory cells; slippery elm was among them. | 13 |
K. Biological pathways
L. Active compounds
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Mucilage (galactose- and other-sugar polysaccharide) | Biological association | In vitro | Forms a gel with water; the traditional basis of the demulcent (soothing, coating) use. Not measured in people. Preparation or compound: Inner bark |
7 8 |
| D-Galactose (sugar unit of the mucilage) | Biological association | In vitro | A 1950 paper title reports a methylated form (3-methyl D-galactose) from the mucilage breakdown; amounts not read. Preparation or compound: Inner bark mucilage |
8 |
| Tannins (for example gallic acid CID 370, tannic acid CID 16129778) | Biological association | In vitro | The KCNQ5 paper says gallic acid and tannic acid are common to the active barks tested; it does not say how much slippery elm contains. Preparation or compound: Bark |
13 |
Each connection is stored with the ingredient, the connected record, the kind of connection, the evidence status, the supporting studies, the preparation or compound involved, and a review date (last reviewed October 25, 2026).
Evidence at a glance: what changed in 13 lab markers
Tap a number to show only those markers. Counts are markers, not people.
The evidence
The research centre for Slippery Elm. Every record here was checked against PubMed or the publisher's page; we never list a study we have not verified.
Evidence by outcome
Bars show how many studies we found for each outcome, not how well it works. People are added up across trials only (reviews are not added, to avoid double counting).
How we rate evidence
High certainty
Several well-run trials or reviews agree; further research is unlikely to change the picture much.
Moderate certainty
Good trials point the same way, but some doubt remains.
Low certainty
Small, short or inconsistent trials. The finding could change with better research.
Very low certainty
Very little or very weak human data. Treat as a possibility only.
Mixed findings
Trials or reviews disagree with each other.
Not enough evidence
Not enough human research to say either way.
Evidence against
Good research found no benefit, or found harm.
We take the reviewers' own risk-of-bias and GRADE statements where they exist, and otherwise judge from study size, design, consistency, directness and whether a product matches what is sold. Many publications do not make evidence high. Method note: We searched PubMed, read the abstracts of every study cited, read the US government LiverTox summary, the Memorial Sloan Kettering and WebMD and RxList pages, the United Plant Savers article and the current text of the main FDA cough and cold rule.
Study library: every study we checked 31
| Study | Design | People | Product, dose, length | Result |
|---|---|---|---|---|
| Ahuja 2019 Popular Remedies for Esophageal Symptoms: a Critical Appraisal. Curr Gastroenterol Rep · PMID 31289950 · DOI |
Narrative review |
Popular remedies for reflux and non-cardiac chest pain (review) | Dietary changes, apple cider vinegar, melatonin, acupuncture and herbal products including slippery elm, among others |
The abstract lists slippery elm among several herbal products being researched for reflux and chest pain and says a substantial gap remains between anecdote and evidence for most non-drug remedies. It gives no result for slippery elm. No numbers given for slippery elm Methods, limits and fundingOutcomes: Clinical use and mechanisms of popular remedies for oesophageal symptoms Limitations: Only the abstract was read. Narrative review, not a systematic one. Funding and conflicts: No conflict statement in the abstract. Read: abstract |
| Ainsworth-Davis 1932 A Piece of Slippery Elm Removed from the Bladder. Proc R Soc Med · PMID 19988576 · DOI |
Case report |
1 A patient with a piece of slippery elm found in the bladder (1932 case report) |
Slippery elm (form not known; abstract not available) bark (presumed) Unknown Unknown |
Only the title was read: a piece of slippery elm removed from the bladder. No abstract is available. None Methods, limits and fundingOutcomes: Foreign body in the bladder Limitations: Only the title was seen. Funding and conflicts: Not stated. Read: summary-only |
| Amado 2021 Subserous Type of Eosinophilic Colitis: A Rare Disease. Eur J Case Rep Intern Med · PMID 34377693 · DOI |
Case report |
1 One woman with subserous eosinophilic colitis, Portugal |
An Ulmus rubra-rich product (details not in abstract) bark (presumed) |
The authors say the colitis was potentially triggered by taking an Ulmus rubra-rich product. They do not claim proof. Single case Methods, limits and fundingOutcomes: Diagnosis and likely trigger of eosinophilic colitis Limitations: One person; a possible trigger is not proof; no re-challenge reported in the abstract. Funding and conflicts: No competing interests declared. Read: abstract |
| Brinckmann 2003 Safety and efficacy of a traditional herbal medicine (Throat Coat) in symptomatic temporary relief of pain in patients with acute pharyngitis: a multicenter, prospective, randomized, double-blinded, placebo-controlled study. J Altern Complement Med · PMID 12804082 · DOI |
Controlled trial |
60 Adults (18+) with acute pharyngitis (sore throat), three US primary care clinics |
Throat Coat, a multi-herb demulcent tea (Traditional Medicinals); the abstract does not list the herbs, so the slippery elm share is unknown multi-herb (not stated in abstract) 5-8 oz, 4-6 times a day 2 to 7 days · vs Placebo tea |
Pain on swallowing was lower with Throat Coat than with placebo tea at 5, 10, 15, 20 and 30 minutes after the first dose. SPID least-squares mean -43.8 (SEM 11.9) with Throat Coat versus -16.5 (SEM 13.9) with placebo (p = 0.012). TOTPAR 53.6 (SEM 10.9) versus 32.4 (SEM 12.8) (p = 0.031). Relief was temporary. SPID p = 0.012; TOTPAR p = 0.031 (valid-for-efficacy analysis) Methods, limits and fundingOutcomes: Pain on swallowing: sum of pain intensity differences (SPID) and total pain relief (TOTPAR) over the first 30 minutes after the first dose Limitations: A combination tea, so the result cannot be credited to slippery elm. Small (60 people). Follow-up of only a few days. A warm drink and honey-like placebo effects are possible, and the placebo tea may not have matched the taste. Funding not stated in the abstract; the product belongs to the company named in the paper (Traditional Medicinals). Funding and conflicts: Funding not stated in the abstract. The trial tested a commercial product, so an industry link is likely but not confirmed. Read: abstract |
| Brown 2004 Medical nutrition therapy as a potential complementary treatment for psoriasis--five case reports. Altern Med Rev · PMID 15387720 |
Case series |
5 Five adults with chronic plaque psoriasis, USA |
A whole-diet programme based on Edgar Cayce readings (fruit and vegetables, fish and fowl, fibre supplements, olive oil, no red meat or processed foods) with daily saffron tea and slippery elm bark water bark (as drink, one part of a whole programme) 6 months |
Average PASI 18.2 to 8.7 and PSS 14.6 to 5.4; permeability ratio 0.066 to 0.026. The authors call for more research. PASI 18.2 to 8.7 (average of 5 people) Methods, limits and fundingOutcomes: Psoriasis Area and Severity Index, Psoriasis Severity Scale, lactulose/mannitol permeability Limitations: Five people, no control group, many changes at once (diet, supplements, a 10-day live-in programme). Slippery elm cannot be credited. Funding and conflicts: Not stated in the abstract. Read: abstract |
| Choi 2002 Peroxynitrite scavenging activity of herb extracts. Phytother Res · PMID 12112294 · DOI |
Laboratory research in-vitro |
Chemical tests on 28 herb extracts | Extracts of 28 herbs including slippery elm bark · vs Other herbs |
Slippery elm was fifth in potency of those the abstract ranked (witch hazel bark > rosemary > jasmine tea > sage > slippery elm > black walnut leaf > Queen Anne's lace > linden flower). Rank 5 in the abstract list Methods, limits and fundingOutcomes: Peroxynitrite scavenging Limitations: Test tube only. Funding and conflicts: Not stated in the abstract. Read: abstract |
| GILL 1946 Constitution of the mucilage from the bark of Ulmus fulva (slippery elm mucilage); the sugars formed in the hydrolysis of the methylated mucilage. J Chem Soc · PMID 20282480 · DOI |
Chemistry in-vitro |
Laboratory chemistry (1946) | Slippery elm bark mucilage, methylated and broken down bark |
Only the title was read: it studies the sugars formed on hydrolysis of the methylated mucilage of Ulmus fulva bark. None Methods, limits and fundingOutcomes: Sugars formed when the mucilage is broken down Limitations: Title only; no abstract. Funding and conflicts: Not stated. Read: summary-only |
| HOUGH 1950 Chemical constitution of slippery elm mucilage; isolation of 3-methyl d-galactose from the hydrolysis products. Nature · PMID 15400433 · DOI |
Chemistry in-vitro |
Laboratory chemistry (1950) | Slippery elm bark mucilage bark |
Only the title was read: it reports isolating 3-methyl D-galactose from the hydrolysis products of slippery elm mucilage. None Methods, limits and fundingOutcomes: Sugar content of the mucilage Limitations: Title only; no abstract. Funding and conflicts: Not stated. Read: summary-only |
| Hawrelak 2010 Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study. J Altern Complement Med · PMID 20954962 · DOI |
Open label uncontrolled |
31 Adults meeting Rome II criteria for irritable bowel syndrome (21 diarrhoea-predominant or alternating, 10 constipation-predominant), Australia, recruited 2001 |
Two powdered herbal formulas. DA-IBS: bilberry fruit, slippery elm bark, agrimony aerial parts, cinnamon quills. C-IBS: slippery elm bark, lactulose, oat bran, licorice root bark (plus other herbs and fibre) |
C-IBS group (constipation-predominant, n=10): bowel movement frequency up 20% (p = 0.016); less straining (p < 0.0001), abdominal pain (p = 0.032), bloating (p = 0.034); better stool consistency (p < 0.0001). DA-IBS group (n=21): small rise in bowel frequency (p = 0.027) and fewer symptoms, but the authors say it was not effective for bowel habit in this group. C-IBS: +20% bowel movement frequency (p = 0.016) Methods, limits and fundingOutcomes: Bowel movement frequency, stool consistency, straining, abdominal pain, bloating, flatulence, global IBS symptoms Limitations: Open-label with no control group, 31 people, only 10 in the constipation group. Both formulas are mixtures; lactulose and oat bran in C-IBS are known to ease constipation by themselves, so slippery elm cannot be credited. No blinding. Funding and conflicts: No funding statement in the abstract; first author is affiliated with a naturopathic practice. Read: abstract |
| Langmead 2002 Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study. Aliment Pharmacol Ther · PMID 11860402 · DOI |
Laboratory research in-vitro |
Cell-free chemical tests and biopsies from people with active ulcerative colitis | Extracts of slippery elm, fenugreek, devil's claw, Mexican yam, tormentil and wei tong ning; 5-ASA (mesalazine) for comparison bark · vs 5-ASA |
All herbs except fenugreek scavenged superoxide in a dose-dependent way. All materials scavenged peroxyl radicals. Oxygen radical release from inflamed colon biopsies fell after incubation with all herbs except Mexican yam, and with 5-ASA. Dose-dependent scavenging; no numbers in abstract Methods, limits and fundingOutcomes: Superoxide and peroxyl radical scavenging; oxygen radical release from colon biopsies Limitations: Laboratory test tubes and biopsy tissue only, not people taking the herb by mouth. Antioxidant activity in a dish does not show a benefit in the body. Funding and conflicts: No conflict statement in the abstract. Read: abstract |
| Leonard 2006 Essiac tea: scavenging of reactive oxygen species and effects on DNA damage. J Ethnopharmacol · PMID 16226859 · DOI |
Laboratory research in-vitro |
Test-tube chemistry and a mouse macrophage cell line | Essiac tea (burdock, sheep sorrel, Ulmus rubra and Indian rhubarb), boiled 25 mg/mL extract inner bark (one of four herbs) 5-50% dilutions of the tea |
At the 50% preparation, signals of hydroxyl and superoxide radicals fell by up to 84% and 82%; hydroxyl-induced DNA damage was prevented and lipid peroxidation fell by up to 50%. Up to 84% (hydroxyl) and 82% (superoxide) lower radical signal Methods, limits and fundingOutcomes: Free radical scavenging, DNA damage, lipid peroxidation Limitations: A four-herb tea in a dish. No human data. Funding and conflicts: Not stated in the abstract. Read: abstract |
| LiverTox (NIDDK) 2024 Slippery Elm. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury (NIDDK), updated 5 Jan 2024 · PMID 38289993 |
Authoritative guidance |
Reference entry on liver injury from herbs | Slippery elm (Ulmus rubra) inner bark preparations inner bark |
LiverTox (NIDDK) says the inner bark is used by mouth for sore throat and stomach upset and on the skin for rash and irritation, that slippery elm preparations are generally recognized as safe, and that there is no evidence they cause raised liver enzymes or clinically apparent liver injury. No liver signal reported Methods, limits and fundingOutcomes: Liver safety Limitations: Only the abstract was read. An absence of reports is not proof of safety. Funding and conflicts: Government reference. Read: abstract |
| Manville 2022 KCNQ5 activation by tannins mediates vasorelaxant effects of barks used in Native American botanical medicine. FASEB J · PMID 35997997 · DOI |
Laboratory research in-vitro |
Frog egg cells (Xenopus oocytes) carrying a human potassium channel, and rat arteries | Bark extracts (1%) of birch, cramp bark, slippery elm, white oak, red willow, white willow and wild cherry bark 1% extract · vs Other barks |
Slippery elm bark extract strongly activated the KCNQ5 potassium channel in oocytes. The artery-relaxing tests were done only on red willow, white willow and white oak (they relaxed rat arteries); slippery elm was not reported as tested in arteries in the abstract. Not a human result Methods, limits and fundingOutcomes: KCNQ5 channel activation; blood vessel relaxation Limitations: Cell and animal tissue only. Slippery elm was not shown to relax arteries. Funding and conflicts: Authors declare no competing interests. Read: abstract |
| McDowell 1837 Elm Bark in Surgery: An Account of the Use of the Bark of the Slippery Elm Tree (Ulmus Fulva), for Bougies, Tents, Catheters, and Similar Purposes in Surgery. West J Med Phys Sci · PMID 38080966 |
Historical article |
Surgeons, 1837 | Slippery elm bark swollen in water for surgical bougies, tents and catheters (title only) bark |
Only the title and index record were seen: "Elm Bark in Surgery: An Account of the Use of the Bark of the Slippery Elm Tree (Ulmus Fulva), for Bougies, Tents, Catheters, and..." (title is cut off in the record). None Methods, limits and fundingOutcomes: History of surgical use Limitations: Title only; historical context for the bladder case reports. Funding and conflicts: Not stated. Read: summary-only |
| Peterson 2018 Prebiotic Potential of Herbal Medicines Used in Digestive Health and Disease. J Altern Complement Med · PMID 29565634 · DOI |
Laboratory research in-vitro |
Human stool samples grown anaerobically in the laboratory | Ulmus rubra, Glycyrrhiza glabra (licorice) and triphala added to stool cultures bark · vs Unsupplemented cultures |
Ulmus rubra and triphala significantly raised the relative abundance of butyrate-producing bacteria. The herbs raised many bacteria considered helpful (Bifidobacterium, Lactobacillus, Bacteroides) and lowered some potential pathogens in the dish. No numbers in abstract Methods, limits and fundingOutcomes: Bacterial species abundance by 16S sequencing; butyrate-producing bacteria Limitations: Fermentation in a dish, not in people. The authors say human trials are needed. Two authors are linked to the Chopra Foundation (disclosed). Funding and conflicts: D.C. and P.J.M. have disclosed Chopra Foundation roles. Read: abstract |
| Rahman 2017 Drug-Herb Interactions in the Elderly Patient with IBD: a Growing Concern. Curr Treat Options Gastroenterol · PMID 28918484 · DOI |
Narrative review |
Older people with inflammatory bowel disease (Crohn disease, ulcerative colitis) (review of herbs and drug interactions) | About 25 herbs and supplements including Ulmus rubra (slippery elm bark) bark |
The abstract lists Ulmus rubra among the herbs reviewed for evidence in IBD and for interactions with IBD drugs. The abstract does not give the slippery elm findings. None in abstract Methods, limits and fundingOutcomes: Herb background, evidence in IBD and possible interactions with IBD medicines Limitations: Only the abstract was read, so the slippery elm section of the review was not seen. Funding and conflicts: No conflict statement in the abstract. Read: abstract |
| Ried 2020 Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders. Nutr Res · PMID 32151878 · DOI |
Pre post study |
43 Australian adults with digestive disorders (upper and lower gut symptoms); 43 completed |
Nutrition Care Gut Relief Formula: curcumin, Aloe vera, slippery elm, guar gum, pectin, peppermint oil, glutamine (amounts of each not stated in the abstract) bark (one of seven ingredients) 5 g/day then 10 g/day for 4 weeks each (after a control phase) 16 weeks in total · vs Own control phase (no placebo group) |
Authors report symptom frequency and severity improved by 60 to 80%; most people with normal stool had normal permeability at the end; Lactobacillus, Clostridium and Faecalibacterium prausnitzii rose; almost half of those with upper gut symptoms who took proton pump inhibitors no longer needed them. Symptoms improved 60-80% (authors); about half of PPI users stopped (authors) Methods, limits and fundingOutcomes: Validated symptom questionnaires (Leeds Dyspepsia, Bristol Stool Chart, Birmingham IBS), intestinal permeability (lactulose to mannitol ratio), gut microbiota, proton pump inhibitor use Limitations: Seven-ingredient formula, so slippery elm cannot be credited. No placebo group, no blinding, small. Self-reported symptoms. Stopping medicines is a result of the study design and should not be copied at home. Funding and conflicts: Not stated in the abstract. Authors are from an integrative medicine institute and the formula carries a company brand name, so an industry link is possible. Read: abstract |
| Shahrajabian 2024 Iranian Traditional Medicine (ITM) and Natural Remedies for Treatment of the Common Cold and Flu. Rev Recent Clin Trials · PMID 38047364 · DOI |
Narrative review |
Traditional Iranian medicine for colds and flu (review) | Many plants; slippery elm listed as expectorant and as immune-stimulating bark |
The abstract lists slippery elm among expectorant and immunostimulant plants for colds and flu. It reports no trial result for slippery elm. None Methods, limits and fundingOutcomes: Literature on herbs for colds and flu Limitations: A literature overview listing traditional uses. Only the abstract was read. It is not evidence that slippery elm works. Funding and conflicts: Not stated in the abstract. Read: abstract |
| Tinsley 2019 A Purported Detoxification Supplement Does Not Improve Body Composition, Waist Circumference, Blood Markers, or Gastrointestinal Symptoms in Healthy Adult Females. J Diet Suppl · PMID 29958034 · DOI |
Controlled trial |
22 Healthy young women (22 completed) |
Multi-ingredient "detox" supplement: papaya leaf, cascara sagrada bark, slippery elm bark, peppermint leaf, red raspberry leaf, fenugreek seed, ginger root and senna leaf (proprietary blend, 1,350 mg per serving) bark (one of eight ingredients) 1,350 mg per serving, daily 4 weeks · vs Placebo |
No beneficial or harmful effects on body composition, waist, stomach and bowel symptoms or blood markers. The authors call the product apparently safe in healthy young women but not beneficial for those outcomes. No difference versus placebo Methods, limits and fundingOutcomes: Body composition, waist circumference, gastrointestinal symptoms, blood safety markers Limitations: Tiny trial in healthy women, not people with symptoms. A blend including two laxatives (cascara, senna) and seven other herbs; slippery elm cannot be separated out. Funding and conflicts: Not stated in the abstract. Read: abstract |
| WILLIAMS 1954 Two cases of slippery elm bladder calculus in pregnancy. J Obstet Gynaecol Br Emp · PMID 13192523 · DOI |
Case report |
2 Two women, pregnant, with a bladder stone formed around slippery elm (1954 case report) |
Slippery elm (form not known; abstract not available) bark (presumed) Unknown Unknown |
Only the title was read: it describes two cases of a bladder stone made of slippery elm during pregnancy. No abstract is available in PubMed, so how the elm reached the bladder is not known from what we read. None Methods, limits and fundingOutcomes: Bladder stone (calculus) in pregnancy Limitations: Only the title and index record were seen; do not read more into it than the title says. Funding and conflicts: Not stated. Read: summary-only |
| Wijesundara 2019 Bactericidal and Anti-Biofilm Activity of Ethanol Extracts Derived from Selected Medicinal Plants against Streptococcus pyogenes. Molecules · PMID 30909644 · DOI |
Laboratory research in-vitro |
Streptococcus pyogenes (the bacterium behind strep throat) grown in the laboratory | Ethanol extracts of 14 plants, including slippery elm inner bark inner bark · vs Other plant extracts |
Licorice root, purple coneflower flower and stem, sage leaf and slippery elm inner bark extracts were among the most effective: minimum inhibitory concentration 62.5 microgram/mL and minimum bactericidal concentration 125 microgram/mL. The authors singled out sage leaf and purple coneflower flower as the most promising candidates. MIC 62.5 microgram/mL; MBC 125 microgram/mL Methods, limits and fundingOutcomes: Minimum inhibitory and bactericidal concentrations; biofilm inhibition Limitations: Alcohol extracts in a dish. A tea, lozenge or powder swallowed by a person is not the same. No human data. Funding and conflicts: The authors declare no conflict of interest. Read: abstract |
| Zick 2006 Trial of Essiac to ascertain its effect in women with breast cancer (TEA-BC). J Altern Complement Med · PMID 17212569 · DOI |
Cohort retrospective |
510 Women randomly chosen from the Ontario cancer registry with breast cancer diagnosed in 2003 |
Essiac, a blend of burdock root, Indian rhubarb, sheep sorrel and slippery elm inner bark (Resperin Canada) inner bark (one of four herbs) Total daily dose 43.6 +/- 30.8 mL (label directions) · vs Women who never used Essiac |
Essiac did not improve quality of life or mood. Users did slightly worse on two subscales (physical well-being, relationship with doctor), possibly because users had more advanced disease. Only 2 women reported minor adverse events. No benefit on quality of life Methods, limits and fundingOutcomes: Health-related quality of life (FACT-B), depression, anxiety, fatigue, adverse events Limitations: Observational, so users and non-users differ. A four-herb blend. Self-reported. Funding and conflicts: Not stated in the abstract. Read: abstract |
| s-ecfr-21cfr-341-310-201 eCFR Title 21: Part 341 (cold, cough, allergy OTC drugs), section 310.545 and section 201.319 (2025-10-01 text) · Source |
Regulation n/a |
Methods, limits and fundingRead: full-text | ||
| s-gbif-ulmus-rubra GBIF Backbone: Ulmus rubra Muhl. (usageKey 5361867) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text | ||
| s-mskcc-slippery-elm Memorial Sloan Kettering: Slippery Elm (Ulmus rubra) · Source |
Consumer reference n/a |
Methods, limits and fundingRead: full-text | ||
| s-ncbi-taxonomy-ulmus-rubra NCBI Taxonomy: Ulmus rubra (taxid 102693) · Source |
Reference database n/a |
Methods, limits and fundingRead: full-text | ||
| s-rxlist-slippery-elm RxList: Slippery Elm (medical editor J. Cunha; cites Medscape) · Source |
Consumer reference n/a |
Methods, limits and fundingRead: full-text | ||
| s-traditional-medicinals-throat-coat Traditional Medicinals: Throat Coat product page (current label) · Source |
Manufacturer page n/a |
Methods, limits and fundingRead: full-text | ||
| s-ups-slippery-elm-burkhart United Plant Savers: Slippery Elm in the Herbal Marketplace - Past, Present & Future (E. Burkhart) · Source |
Conservation report n/a |
Methods, limits and fundingRead: full-text | ||
| s-webmd-slippery-elm WebMD: Slippery Elm - Uses, Side Effects, and More (reviewed 29 Sep 2025) · Source |
Consumer reference n/a |
Methods, limits and fundingRead: full-text | ||
| s-wikipedia-ulmus-rubra Wikipedia: Ulmus rubra (NOT verified against primary sources) · Source |
Encyclopedia n/a |
Methods, limits and fundingRead: full-text |
What we do not know yet
- What the evidence supports: a short-term sore throat benefit from one multi-herb tea (low certainty).
- What is uncertain: whether slippery elm itself does anything for the throat, stomach, bowel or skin.
- No trial of slippery elm alone for any condition was found.
- No study measured whether it changes the absorption of other medicines.
- No data on pregnancy or breastfeeding beyond cautions from consumer references without trials.
- No testing of products for adulteration or other elm species.
How new research is added
New studies are found by a saved PubMed search and are placed in a review queue. A person reads each one before it is added.
Lab markers
What changed in blood or saliva tests during trials. A changed number is not the same as feeling or being healthier, and we give no "normal ranges".
Other 13
Throat pain on swallowing
Lowered in trials
A rating of how much it hurts to swallow, scored repeatedly after a drink.
Low certaintyResults and what it means
Why it was measured
The main outcome of the Throat Coat trial.
Statistical vs. clinical meaning
Statistically significant over 30 minutes after the first dose; how long the relief lasted beyond that is not shown.
Safety implication
None specific.
| Study | Result | People | Product |
|---|---|---|---|
| 4 | SPID -43.8 (SEM 11.9) with Throat Coat versus -16.5 (SEM 13.9) with placebo, p = 0.012; TOTPAR 53.6 versus 32.4, p = 0.031 | Adults with acute pharyngitis, n=60 | Multi-herb demulcent tea containing slippery elm (label order, current product) |
Bacterial growth stopped in a dish (MIC and MBC)
Lowered in trials
The smallest amount of an extract that stops (MIC) or kills (MBC) bacteria in a laboratory dish.
Very low certaintyResults and what it means
Why it was measured
A first screen for activity against the bacterium behind strep throat.
Statistical vs. clinical meaning
A laboratory number only; not a human outcome.
Safety implication
None.
| Study | Result | People | Product |
|---|---|---|---|
| 21 | MIC 62.5 microgram/mL and MBC 125 microgram/mL for the most effective extracts, including slippery elm inner bark | Streptococcus pyogenes in the laboratory | Ethanol extract of slippery elm inner bark |
Digestive symptom questionnaire scores
Lowered in trials
Questionnaires that score indigestion, heartburn, nausea and bowel symptoms.
Very low certaintyResults and what it means
Why it was measured
The main outcome of the formula study.
Statistical vs. clinical meaning
Self-reported, no placebo group.
Safety implication
Do not stop acid-reducing medicines without your doctor.
| Study | Result | People | Product |
|---|---|---|---|
| 17 | Authors report 60-80% improvement in frequency and severity of upper and lower gut symptoms (numbers per item not in abstract) | 43 adults with digestive disorders | Seven-ingredient formula including slippery elm, 5 then 10 g/day |
Use of proton pump inhibitor medicines
Lowered in trials
Whether people still took acid-reducing medicines at the end of the study.
Very low certaintyResults and what it means
Why it was measured
A practical sign of heartburn control.
Statistical vs. clinical meaning
Uncontrolled; depends on how the study guided medicine changes.
Safety implication
Medicine changes only with a doctor.
| Study | Result | People | Product |
|---|---|---|---|
| 17 | Almost half of participants with upper gut symptoms who were on proton pump inhibitors no longer needed them by the end (authors) | Adults with upper gut symptoms | Seven-ingredient formula including slippery elm |
Free radical scavenging in the laboratory
Lowered in trials
How well an extract neutralises reactive oxygen molecules in test tubes.
Very low certaintyResults and what it means
Why it was measured
Screening for antioxidant activity.
Statistical vs. clinical meaning
Lab only.
Safety implication
None.
| Study | Result | People | Product |
|---|---|---|---|
| 10 | Superoxide scavenged dose-dependently; peroxyl scavenged; oxygen radical release from inflamed colon biopsies reduced (no numbers in abstract) | Cell-free systems and colitis biopsies | Slippery elm extract |
| 6 | Slippery elm ranked fifth of the eight herbs listed for peroxynitrite scavenging | 28 herb extracts | Slippery elm extract |
Bowel movement frequency
Raised in trials
How many times a week or day a person has a bowel movement.
Very low certaintyResults and what it means
Why it was measured
A basic outcome for constipation-type IBS.
Statistical vs. clinical meaning
Open-label with no control group.
Safety implication
None.
| Study | Result | People | Product |
|---|---|---|---|
| 9 | C-IBS group: +20% (p = 0.016); DA-IBS group: small but significant rise (p = 0.027) | 31 adults with IBS | Two herbal mixtures containing slippery elm bark |
Stool consistency
Mixed results in trials
How hard or soft stool is, often rated on a chart.
Very low certaintyResults and what it means
Why it was measured
Tracks constipation or diarrhoea.
Statistical vs. clinical meaning
Lactulose and oat bran in the constipation blend can soften stool alone.
Safety implication
None.
| Study | Result | People | Product |
|---|---|---|---|
| 9 | Improved in the constipation group (p < 0.0001); the diarrhoea/mixed group did not improve bowel habit | 31 adults with IBS | Two herbal mixtures containing slippery elm bark |
Abdominal pain, bloating and straining
Lowered in trials
Patient-rated gut discomfort scores.
Very low certaintyResults and what it means
Why it was measured
Core IBS symptoms.
Statistical vs. clinical meaning
No placebo group, so improvement could be natural fluctuation or expectation.
Safety implication
None.
| Study | Result | People | Product |
|---|---|---|---|
| 9 | C-IBS: straining p < 0.0001, abdominal pain p = 0.032, bloating p = 0.034; DA-IBS: straining p = 0.004, pain p = 0.006, bloating p < 0.0001 | 31 adults with IBS | Two herbal mixtures containing slippery elm bark |
Intestinal permeability (lactulose-to-mannitol ratio)
Lowered in trials
A urine test of how much of two sugars passes through the gut lining.
Very low certaintyResults and what it means
Why it was measured
Used as a rough measure of "leaky gut".
Statistical vs. clinical meaning
A test result; the link to how people feel is unclear.
Safety implication
None.
| Study | Result | People | Product |
|---|---|---|---|
| 17 | Most participants had normal ratios by the end (all with normal stool, 90% with hard stool, 66% with soft stool) | 43 adults with digestive disorders | Seven-ingredient formula including slippery elm |
| 5 | Average ratio 0.066 to 0.026 over six months | 5 adults with psoriasis | Whole-diet programme with slippery elm bark water |
Gut bacteria mix
Raised in trials
Which bacteria are present and in what amounts.
Very low certaintyResults and what it means
Why it was measured
Gut bacteria are linked to digestion and inflammation.
Statistical vs. clinical meaning
More of a bacterium is not the same as better health.
Safety implication
None.
Body composition and waist circumference
No clear change in trials
Fat and lean mass, and waist measurement.
Low certaintyResults and what it means
Psoriasis severity scores (PASI, PSS)
Lowered in trials
Doctor-rated skin scores.
Very low certaintyHealth-related quality of life in breast cancer (FACT-B)
No clear change in trials
A questionnaire scoring physical, emotional and social well-being.
Low certaintyResults and what it means
Why it was measured
Main outcome of the Essiac cohort.
Statistical vs. clinical meaning
Observational; users had more advanced disease.
Safety implication
Only 2 women reported minor adverse events.
| Study | Result | People | Product |
|---|---|---|---|
| 22 | No significant improvement; users did worse on physical well-being and relationship-with-doctor subscales | 510 women with breast cancer | Essiac (includes slippery elm), about 44 mL/day |
Safety
What studies and official sources say about side effects, medicines and who should check first. Each point shows what kind of evidence it comes from.
Main points to know 7
- Mucilage can get in the way of other medicines. Slippery elm is rich in mucilage, a gel-forming fibre. WebMD says it "may affect the absorption of some medicines" and that how it interacts with medicines is not fully understood. This is a theory based on how gels and fibres behave in the gut. We found no study that measured the blood levels of any medicine taken with slippery elm. Because the effect is unmeasured, ask a pharmacist how far apart to take your medicines and slippery elm. Pharmacological theory 30
- Allergy is possible, and one case report links it to a bowel reaction. WebMD says serious allergic reactions are possible (hives, facial swelling, trouble breathing). RxList lists allergic reaction and contact dermatitis. A 2021 case report from Portugal describes a woman whose rare eosinophilic colitis (an allergy-like bowel inflammation) was potentially triggered by an Ulmus rubra-rich product. One case shows something happened, not how often. Case report 30 27 3
- Pregnancy: avoid, because safety is unknown and an old warning exists. WebMD says it is not known how slippery elm might affect pregnancy. RxList states that slippery elm is an abortifacient that may cause miscarriage (whole bark) and says to avoid it in pregnancy and breastfeeding, but gives no source or study in the text we read. The warning appears to come from old folk use of the bark. We did not find a trial or a case series showing miscarriage from slippery elm taken by mouth. Until better information exists, pregnant and breastfeeding women should avoid it or ask their doctor. Traditional use 30 27
- Liver: no sign of harm in LiverTox. The US government LiverTox entry says slippery elm preparations are generally recognized as safe and that there is no evidence they cause raised liver enzymes or clinically apparent liver injury. Authoritative guidance 12
- Blends carry the risks of their other herbs. Most research and most products are blends. Throat Coat lists licorice root, marshmallow, wild cherry bark, fennel, cinnamon and orange peel besides slippery elm. A "detox" blend that was tested contained cascara and senna, which are stimulant laxatives. Read the whole label, not only the slippery elm line. Authoritative guidance 28 19
- The tree is under pressure, so choose carefully sourced products. United Plant Savers puts slippery elm on its At-Risk List because the trade depends on wild-harvested bark and the tree is hit by Dutch elm disease and elm yellows. Globally the species is not endangered (Wikipedia, citing IUCN Least Concern; NOT verified against IUCN). Taking bark can kill a tree if it is stripped all around. Authoritative guidance 29 31
- Do not skip care for a serious problem. A sore throat with fever and no cough may be strep throat, which can need antibiotics. Long-lasting bowel change, blood in stool, weight loss, or chest pain must be checked. The only throat trial lasted a few days and showed short relief. Memorial Sloan Kettering says there is no evidence slippery elm treats infections, cancer or other serious conditions. Authoritative guidance 4 25
Side effects 5
| Effect | How often | Severity and recovery | Evidence |
|---|---|---|---|
| Allergic reaction (hives, swelling, breathing trouble) WebMD says serious allergic reactions may happen. No rate is given. | Not established | can be serious Stop use and get help; outcome not described in sources | Authoritative guidance 30 27 |
| Contact dermatitis (skin rash) Listed by RxList; no source cited for the frequency. | Not established | mild to moderate (not graded) Not described | Authoritative guidance 27 |
| Eosinophilic colitis (rare allergy-type bowel inflammation) The authors say the product potentially triggered it; causation not proven. | One case report | moderate The abstract says this type responds well to corticosteroids; whether the patient recovered after stopping the product is not in the abstract | Case report 3 |
| Minor side effects in blend studies All are blends or uncontrolled; counts from abstracts, not rates for slippery elm alone. | 2 of the Essiac users reported minor adverse events (cohort of 510 women); both IBS formulas were described as well-tolerated (31 people); no harm in blood markers in 22 healthy women | mild Not described | Cohort study 22 9 19 |
| Bladder stone or foreign body after surgical or insertion use (historical) Titles describe slippery elm found in or forming a stone in the bladder; the 1837 title describes surgical use of the bark. Not oral use as sold today, and not read beyond titles. | Case reports from 1932 and 1954 | unknown Unknown (only titles seen) | Case report 2 20 14 |
Liver
LiverTox (US National Institutes of Health) says slippery elm preparations are generally recognized as safe and that there is no evidence they raise liver enzymes or cause clinically apparent liver injury. None of the studies we read reported liver harm, but their abstracts do not report liver tests except blood safety markers unchanged in the 22-woman blend trial. 12 19
How often. No frequency given. LiverTox found no evidence of injury. Not finding reports is not proof of safety.
Monitoring. No monitoring advice given. Products that mix in licorice or other herbs have their own liver and blood-pressure notes.
This is a safety connection. It is not evidence that Slippery Elm supports liver health.
Medicines and supplements 4
| With | Why it matters | Importance | Evidence | What to do |
|---|---|---|---|---|
| Any medicine taken by mouth at the same time (general) prescription | Mucilage forms a gel and could slow or reduce absorption of other swallowed substances. This is a theory about how fibre behaves; no blood-level study of slippery elm was found. | WebMD says it may affect absorption of some medicines and that the interactions are not fully understood. RxList says no known severe interactions, with no source shown. These two sources disagree. One web search summary reported a database advising to space doses by one to two hours; we could not read that database, so we do not give a number as fact. | Pharmacological theory Not enough evidence 30 27 | Ask your pharmacist how long to leave between slippery elm and each medicine. Do not stop a medicine on your own. |
| Medicines where small changes in the amount absorbed matter (for example thyroid hormone, blood thinners, seizure medicines, heart rhythm medicines, contraception) prescription | Same theory as above. The examples are our reasoning from the mucilage idea; none was tested with slippery elm. | No studies and no case reports with slippery elm were found for these medicines. | Pharmacological theory Not enough evidence 30 | Tell your pharmacist and doctor before starting; they may suggest spacing or checking blood tests. |
| Inflammatory bowel disease medicines taken by mouth prescription | A review of herb-drug interactions in older people with IBD covers Ulmus rubra; the abstract does not give the details. | Not seen (abstract only). The mucilage theory applies. | Authoritative guidance Not enough evidence 16 | Talk to your gastroenterologist before adding it. |
| Other laxatives or stimulant herbs in a blend (cascara, senna, rhubarb) herb | Some blends that contain slippery elm also contain stimulant laxatives, so their effects add up. | The detox trial blend contained cascara and senna; Essiac contains Indian rhubarb. Interaction with slippery elm itself not studied. | Authoritative guidance Not enough evidence 19 22 | Check the label for laxative plants. |
Who should check first 4
| Situation | Advice | Evidence |
|---|---|---|
| Allergy to slippery elm or any ingredient in the product | Do not use. WebMD and RxList list this. | Authoritative guidance 30 27 |
| Pregnancy and breastfeeding | Avoid unless your doctor agrees. Safety is unknown; RxList calls whole bark an abortifacient (source not shown). | Traditional use 30 27 |
| A past allergy-type bowel inflammation (eosinophilic colitis) | Avoid unless your gastroenterologist agrees; this rests on one case report. | Case report 3 |
| Taking time-critical swallowed medicines | Ask a pharmacist about timing before use. | Pharmacological theory 30 |
Overdose, product quality and regulators
Summary. No toxic dose of slippery elm bark is documented in the sources we read. LiverTox says preparations are generally recognized as safe.
Animal. No animal toxicity study was found in this search.
Human doses studied. Only blends were studied: a gut formula at 5 then 10 g a day for 4 weeks each, a 1,350 mg-per-serving detox blend for 4 weeks, and Essiac at about 44 mL a day. Slippery elm amounts inside them are not in the abstracts.
High dose or long term signals. Not found. Long-term use of slippery elm alone has not been studied.
Overdose response. Not found. RxList advises calling a Poison Control Center in case of overdose (general text).
Genotoxicity. Not found.
Toxic plant parts. No toxic part of the bark was identified in the sources read. Leaves are sometimes made into tea per Wikipedia (NOT verified); inner bark is the studied part.
We found no published testing of slippery elm products for adulteration, heavy metals, or species mix-ups, so a product-quality picture cannot be given. Dutch elm disease is a disease of the tree, not a proven contaminant of bark products.
Adulteration and other elm species. No analysis of slippery elm powders for substitution with other elm species or fillers was found. The United Plant Savers article does not discuss adulteration. GBIF lists Ulmus fulva only as a synonym of U. rubra, so labels using the old name are still the same species. 29 24
Dutch elm disease and elm yellows. The trees are widely killed by Dutch elm disease and elm yellows and seldom reach commercial size. The same article suggests harvesting dying trees, so some bark may come from diseased trees. No source we read says such bark is unsafe to swallow. 29
Wild harvest and over-harvesting. AHPA surveys cited by United Plant Savers put wild-harvested dried bark at 78,000 to 353,000 pounds a year (1999-2010); cultivated bark is a small share. Reports say about a dozen trees yield fifty pounds of fresh bark. Stripping all around a trunk kills it. 29
Blends. The tested products were blends; hidden extra ingredients (laxative herbs) matter more than contamination of the bark. 19 28
| Body | Action | Date |
|---|---|---|
| US Food and Drug Administration (United States) | WebMD says the FDA has not reviewed slippery elm for safety and effectiveness. In the eCFR text of 21 CFR Part 341 (cold, cough and allergy drugs), section 310.545 and 201.319 (2025-10-01 version), the words "slippery elm" and "elm" do not appear. Part 341 refers to a "generally recognized as safe and effective single oral demulcent" but names none in the text we read. Websites claim FDA lists elm bark as a lozenge demulcent; we could not find that in the regulation. source | 2025-10-01 |
| US National Institutes of Health, LiverTox (United States) | Entry on slippery elm: generally recognized as safe; no evidence of liver injury. source | 2024-01-05 |
| Memorial Sloan Kettering Cancer Center (United States) | Patient page: may relieve minor cough or sore throat; no evidence it treats infections, cancer or other serious conditions. source | |
| United Plant Savers (United States) | Slippery elm on the At-Risk List. source |
When to get medical help
- Hives, swelling of the face or lips, or trouble breathing after taking it: stop and get emergency help.
- Belly pain, bloating or swelling with diarrhoea that does not settle after a product containing slippery elm: see a doctor (rare case of eosinophilic colitis).
- Sore throat with high fever, white patches, or trouble swallowing or breathing: see a doctor; do not rely on slippery elm.
- Blood in stool, black stool, weight loss or heartburn with chest pain: see a doctor.
- You are pregnant and took a large amount of bark or any bark inserted into the body: tell your doctor.
- Taking a time-critical medicine (for example thyroid, seizure or heart rhythm medicine) and unsure about timing: ask your pharmacist.
Stop the supplement and contact a clinician or emergency service. In the US, Poison Control is 1-800-222-1222.
General information only, not medical advice. Ask a clinician or pharmacist before use, especially with medicines, in pregnancy or with a health condition. See the Natural Remedy Safety guide.
Frequently asked questions
What is slippery elm?
Slippery elm (Ulmus rubra, also called red elm; the older name Ulmus fulva is the same tree) is a North American tree. The inner bark is dried and powdered. Mixed with water it makes a slippery gel called mucilage, which is why it has long been used as a soothing remedy for sore throat and an upset stomach.
Does slippery elm help a sore throat?
Does slippery elm help a cough or a cold?
Can slippery elm help heartburn or acid reflux?
It is a popular home remedy, but there is no trial of slippery elm alone. A review of popular reflux remedies lists it among herbs with a gap between stories and proof. A small uncontrolled study of a seven-ingredient blend reported fewer symptoms, but a blend cannot show what slippery elm does.
Does it work for irritable bowel syndrome or constipation?
Unclear. In a small open study, a blend of slippery elm, lactulose, oat bran and licorice root was followed by more frequent, softer stools in 10 people with constipation-type IBS. The other ingredients can ease constipation by themselves, and there was no placebo group.
Is slippery elm useful for Crohn disease or ulcerative colitis?
Does slippery elm treat cancer?
Can slippery elm affect my other medicines?
Possibly. The gel-like mucilage could slow or reduce how much of a swallowed medicine your body absorbs. WebMD says it may affect absorption of some medicines, but this has not been measured in a study, and another reference says there are no known severe interactions. Ask a pharmacist about timing, especially for thyroid, blood-thinning, seizure or heart medicines.
Is slippery elm safe to take?
The US LiverTox entry says slippery elm preparations are generally recognized as safe and found no evidence of liver injury. Allergic reactions are possible, and one case report links an Ulmus rubra-rich product to a rare allergy-type bowel inflammation. Long-term safety has not been studied.
Is slippery elm safe in pregnancy or while breastfeeding?
Is slippery elm an endangered tree?
Not globally (Least Concern on the IUCN list according to Wikipedia, which we have not verified), but United Plant Savers lists it as At-Risk because most bark is taken from wild trees and Dutch elm disease and elm yellows are killing the trees. Stripping bark all the way around a trunk kills it.
Explore by health goal
Digestive SupportGut HealthImmune SupportInflammation BalanceHealthy SkinCalm RelaxationWeight ManagementBlood Pressure Support
Editorial transparency
- Written by
- AlternativeMed editorial team. Research compiled with AI assistance, then checked against PubMed records.
- Medical review
- None. This page has not been reviewed by a physician or pharmacist.
- First published
- 2026-10-25
- Last substantive update
- 2026-10-25
- How we research
- We searched PubMed, read the abstracts of every study cited, read the US government LiverTox summary, the Memorial Sloan Kettering and WebMD and RxList pages, the United Plant Savers article and the current text of the main FDA cough and cold rule.
- How we rate evidence
- See "How we rate evidence" in the Evidence tab.
- Independence
- No product is promoted on this page. No affiliate links are shown. If one is added later it will be labelled as such.
Sources 31
Each source was opened and checked. Where we read only the abstract, it says so. The small numbers in the text point here.
- Ahuja A, Ahuja NK. Popular Remedies for Esophageal Symptoms: a Critical Appraisal.. Curr Gastroenterol Rep. 2019. PMID 31289950. DOI 10.1007/s11894-019-0707-4. (abstract)
- Ainsworth-Davis JC. A Piece of Slippery Elm Removed from the Bladder.. Proc R Soc Med. 1932. PMID 19988576. DOI 10.1177/003591573202500478. (summary-only)
- Amado C, Silva Leal M, Neto P et al.. Subserous Type of Eosinophilic Colitis: A Rare Disease.. Eur J Case Rep Intern Med. 2021. PMID 34377693. DOI 10.12890/2021_002671. (abstract)
- Brinckmann J, Sigwart H, van Houten Taylor L. Safety and efficacy of a traditional herbal medicine (Throat Coat) in symptomatic temporary relief of pain in patients with acute pharyngitis: a multicenter, prospective, randomized, double-blinded, placebo-controlled study.. J Altern Complement Med. 2003. PMID 12804082. DOI 10.1089/10755530360623400. (abstract)
- Brown AC, Hairfield M, Richards DG et al.. Medical nutrition therapy as a potential complementary treatment for psoriasis--five case reports.. Altern Med Rev. 2004. PMID 15387720. (abstract)
- Choi HR, Choi JS, Han YN et al.. Peroxynitrite scavenging activity of herb extracts.. Phytother Res. 2002. PMID 12112294. DOI 10.1002/ptr.904. (abstract)
- GILL RE, HIRST EL, JONES JK. Constitution of the mucilage from the bark of Ulmus fulva (slippery elm mucilage); the sugars formed in the hydrolysis of the methylated mucilage.. J Chem Soc. 1946. PMID 20282480. DOI 10.1039/jr9460001025. (summary-only)
- HOUGH L, JONES JK, HIRST EL. Chemical constitution of slippery elm mucilage; isolation of 3-methyl d-galactose from the hydrolysis products.. Nature. 1950. PMID 15400433. DOI 10.1038/165034a0. (summary-only)
- Hawrelak JA, Myers SP. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study.. J Altern Complement Med. 2010. PMID 20954962. DOI 10.1089/acm.2009.0090. (abstract)
- Langmead L, Dawson C, Hawkins C et al.. Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study.. Aliment Pharmacol Ther. 2002. PMID 11860402. DOI 10.1046/j.1365-2036.2002.01157.x. (abstract)
- Leonard SS, Keil D, Mehlman T et al.. Essiac tea: scavenging of reactive oxygen species and effects on DNA damage.. J Ethnopharmacol. 2006. PMID 16226859. DOI 10.1016/j.jep.2005.09.013. (abstract)
- LiverTox (NIDDK). Slippery Elm.. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury (NIDDK), updated 5 Jan 2024. 2024. PMID 38289993. (abstract)
- Manville RW, Redford KE, van der Horst J et al.. KCNQ5 activation by tannins mediates vasorelaxant effects of barks used in Native American botanical medicine.. FASEB J. 2022. PMID 35997997. DOI 10.1096/fj.202200724R. (abstract)
- McDowell WA. Elm Bark in Surgery: An Account of the Use of the Bark of the Slippery Elm Tree (Ulmus Fulva), for Bougies, Tents, Catheters, and Similar Purposes in Surgery.. West J Med Phys Sci. 1837. PMID 38080966. (summary-only)
- Peterson CT, Sharma V, Uchitel S et al.. Prebiotic Potential of Herbal Medicines Used in Digestive Health and Disease.. J Altern Complement Med. 2018. PMID 29565634. DOI 10.1089/acm.2017.0422. (abstract)
- Rahman H, Kim M, Leung G et al.. Drug-Herb Interactions in the Elderly Patient with IBD: a Growing Concern.. Curr Treat Options Gastroenterol. 2017. PMID 28918484. DOI 10.1007/s11938-017-0154-y. (abstract)
- Ried K, Travica N, Dorairaj R et al.. Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders.. Nutr Res. 2020. PMID 32151878. DOI 10.1016/j.nutres.2020.02.008. (abstract)
- Shahrajabian MH, Sun W. Iranian Traditional Medicine (ITM) and Natural Remedies for Treatment of the Common Cold and Flu.. Rev Recent Clin Trials. 2024. PMID 38047364. DOI 10.2174/0115748871275500231127065053. (abstract)
- Tinsley G, Urbina S, Santos E et al.. A Purported Detoxification Supplement Does Not Improve Body Composition, Waist Circumference, Blood Markers, or Gastrointestinal Symptoms in Healthy Adult Females.. J Diet Suppl. 2019. PMID 29958034. DOI 10.1080/19390211.2018.1472713. (abstract)
- WILLIAMS B. Two cases of slippery elm bladder calculus in pregnancy.. J Obstet Gynaecol Br Emp. 1954. PMID 13192523. DOI 10.1111/j.1471-0528.1954.tb07516.x. (summary-only)
- Wijesundara NM, Rupasinghe HPV. Bactericidal and Anti-Biofilm Activity of Ethanol Extracts Derived from Selected Medicinal Plants against Streptococcus pyogenes.. Molecules. 2019. PMID 30909644. DOI 10.3390/molecules24061165. (abstract)
- Zick SM, Sen A, Feng Y et al.. Trial of Essiac to ascertain its effect in women with breast cancer (TEA-BC).. J Altern Complement Med. 2006. PMID 17212569. DOI 10.1089/acm.2006.12.971. (abstract)
- . eCFR Title 21: Part 341 (cold, cough, allergy OTC drugs), section 310.545 and section 201.319 (2025-10-01 text). . . (full-text)
- . GBIF Backbone: Ulmus rubra Muhl. (usageKey 5361867). . . (full-text)
- . Memorial Sloan Kettering: Slippery Elm (Ulmus rubra). . . (full-text)
- . NCBI Taxonomy: Ulmus rubra (taxid 102693). . . (full-text)
- . RxList: Slippery Elm (medical editor J. Cunha; cites Medscape). . . (full-text)
- . Traditional Medicinals: Throat Coat product page (current label). . . (full-text)
- . United Plant Savers: Slippery Elm in the Herbal Marketplace - Past, Present & Future (E. Burkhart). . . (full-text)
- . WebMD: Slippery Elm - Uses, Side Effects, and More (reviewed 29 Sep 2025). . . (full-text)
- . Wikipedia: Ulmus rubra (NOT verified against primary sources). . . (full-text)
Where to buy
Check the label first. Whatever you buy, look for these:
- The plant part and the extract type or ratio on the label
- A standardized amount of the active compounds, where relevant
- A third-party testing mark (USP, NSF or ConsumerLab)
- Interactions: ask a pharmacist if you take medicines, are pregnant or have a medical condition
Talk to a pharmacist or doctor before you start any supplement, especially if you take medicines. See the Safety tab for interactions.
Support our free guides: as an Amazon Associate we earn from qualifying purchases. Full disclosure.